Altemus M - Search Results

1

Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study.

Greenberg BD, George MS, Martin JD, Benjamin J, Schlaepfer TE, Altemus M, Wassermann EM, Post RM, Murphy DL. Greenberg BD, et al. Among authors: altemus m. Am J Psychiatry. 1997 Jun;154(6):867-9. doi: 10.1176/ajp.154.6.867. Am J Psychiatry. 1997. PMID: 9167520 Clinical Trial.

2

Symptoms of eating disorders in patients with obsessive-compulsive disorder.

Pigott TA, Altemus M, Rubenstein CS, Hill JL, Bihari K, L'Heureux F, Bernstein S, Murphy DL. Pigott TA, et al. Among authors: altemus m. Am J Psychiatry. 1991 Nov;148(11):1552-7. doi: 10.1176/ajp.148.11.1552. Am J Psychiatry. 1991. PMID: 1928472

3

CSF somatostatin in obsessive-compulsive disorder.

Altemus M, Pigott T, L'Heureux F, Davis CL, Rubinow DR, Murphy DL, Gold PW. Altemus M, et al. Am J Psychiatry. 1993 Mar;150(3):460-4. doi: 10.1176/ajp.150.3.460. Am J Psychiatry. 1993. PMID: 8094599

4

Working memory as assessed by subject-ordered tasks in patients with obsessive-compulsive disorder.

Martin A, Wiggs CL, Altemus M, Rubenstein C, Murphy DL. Martin A, et al. Among authors: altemus m. J Clin Exp Neuropsychol. 1995 Oct;17(5):786-92. doi: 10.1080/01688639508405167. J Clin Exp Neuropsychol. 1995. PMID: 8557818

5

Behavioral effects of naloxone infusion in obsessive-compulsive disorder.

Keuler DJ, Altemus M, Michelson D, Greenberg B, Murphy DL. Keuler DJ, et al. Among authors: altemus m. Biol Psychiatry. 1996 Jul 15;40(2):154-6. doi: 10.1016/0006-3223(95)00632-X. Biol Psychiatry. 1996. PMID: 8793049 Clinical Trial. No abstract available.

6

Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder.

Altemus M, Murphy DL, Greenberg B, Lesch KP. Altemus M, et al. Am J Med Genet. 1996 Jul 26;67(4):409-11. doi: 10.1002/(SICI)1096-8628(19960726)67:4<409::AID-AJMG16>3.0.CO;2-N. Am J Med Genet. 1996. PMID: 8837711

7

Hypervigilance in patients with obsessive-compulsive disorder.

Wiggs CL, Martin A, Altemus M, Murphy DL. Wiggs CL, et al. Among authors: altemus m. Anxiety. 1996;2(3):123-9. doi: 10.1002/(SICI)1522-7154(1996)2:3<123::AID-ANXI3>3.0.CO;2-Q. Anxiety. 1996. PMID: 9160613

8

Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients.

Greenberg BD, Benjamin J, Martin JD, Keuler D, Huang SJ, Altemus M, Murphy DL. Greenberg BD, et al. Among authors: altemus m. Psychopharmacology (Berl). 1998 Dec;140(4):434-44. doi: 10.1007/s002130050787. Psychopharmacology (Berl). 1998. PMID: 9888619 Clinical Trial.

9

Open trial of flutamide for treatment of obsessive-compulsive disorder.

Altemus M, Greenberg BD, Keuler D, Jacobson KR, Murphy DL. Altemus M, et al. J Clin Psychiatry. 1999 Jul;60(7):442-5. doi: 10.4088/jcp.v60n0704. J Clin Psychiatry. 1999. PMID: 10453797 Clinical Trial.

10

Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder.

Bengel D, Greenberg BD, Corá-Locatelli G, Altemus M, Heils A, Li Q, Murphy DL. Bengel D, et al. Among authors: altemus m. Mol Psychiatry. 1999 Sep;4(5):463-6. doi: 10.1038/sj.mp.4000550. Mol Psychiatry. 1999. PMID: 10523819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters